JPRN-UMIN000046004招募中未知
Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failure - Acute MI and HF registry in Chiba
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Maintenance hemodialysis 2) eGFR <30 ml/min/1.73 m2 3) Failed PCI (TIMI flow grade 0 or 1) 4) In-hospital death
研究者
相似试验
已完成
不适用
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cancer Risk: A systematic review and network meta-analysisHypertension, Coronary artery disease, Heart failure, Chronic kidney disease, Atrial fibrillation, High risk vascular disease, Cerebrovascular accident, Diabetes mellitus, High normal blood pressure, Pre-hypertensionJPRN-UMIN000048395Yokohama City University Graduate School of Medicine
招募中
Unknown
The effect of an angiotensin receptor-neprilysin inhibitor to blood pressure and sympathoadrenal responses during mental arithmetic stress in patients with essential hypertensioessential hypertensionJPRN-UMIN000051537niversity of Toyama40
进行中（未招募）
1 期
Effect of the drug sacubitril/valsartan on physical performance in patients with hypertrophic cardiomyopathyhypertrophic cardiomyopathyEUCTR2018-004882-15-DEniversity Hospital Regensburg40
进行中（未招募）
1 期
Influences of Sacubitril/Valsartan (ENTRESTO®) on centrally generated sympathetic activity in heart failure patientsChronic heart failure with reduced left ventricular ejection fraction (NYHA II-III)MedDRA version: 20.0Level: LLTClassification code 10078289Term: Heart failure with reduced ejection fractionSystem Organ Class: 100000004849EUCTR2017-000394-36-DEHannover Medical School35
尚未招募
不适用
Effect of angiotensin receptor blockers for neointimal coverage after stent implantation.Hypertensive patients with coronary arteries disease.JPRN-UMIN000007634Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine70